Early research (Phase 1)Study completedNCT04316689What this trial is testingFirst-in-human Study of S-588210 (S-488210+S-488211)Who this might be right forLung CancerHead and Neck CancerBladder Cancer+2 more Shionogi 10
Not applicableStudy completedNCT00580138What this trial is testingReal-Time Internet Evaluation of SwallowingWho this might be right forHead and Neck CancerStroke University of Arkansas 30
Not applicableLooking for participantsNCT06070376What this trial is testingComparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.Who this might be right forEsophageal NeoplasmsDysphagia Instituto do Cancer do Estado de São Paulo 34
Testing effectiveness (Phase 2)Ended earlyNCT00539617What this trial is testingChemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by SurgeryWho this might be right forEsophageal Cancer University of California, San Francisco 7
Not applicableStudy completedNCT05497947What this trial is testingEvaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomyWho this might be right forPharyngeal CancerSwallowing DisorderLarynx Cancer Centre Hospitalier de Valence 225
Large-scale testing (Phase 3)Ended earlyNCT00824785What this trial is testingREAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG CancerWho this might be right forOesophago-gastric Cancer Royal Marsden NHS Foundation Trust 574
Testing effectiveness (Phase 2)UnknownNCT06055166What this trial is testingA Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid TumorsWho this might be right forPARP Inhibitor for Esophageal Squamous Cell Carcinoma Chongqing University Cancer Hospital 120
Not applicableUnknownNCT00155805What this trial is testingImmunologic Factors in Reflux Esophagitis and Barrett's EsophagusWho this might be right forReflux EsophagitisHiatal Hernia National Taiwan University Hospital 90
Early research (Phase 1)Looking for participantsNCT07181473What this trial is testingEvaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsWho this might be right forLung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more Phrontline Biopharma 200
Not applicableStudy completedNCT04973046What this trial is testingTissue Oxygen Saturation for EsophagectomyWho this might be right forEsophageal NeoplasmsEsophagostomy ComplicationAnastomotic Leak+1 more Shizuoka Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT03585673What this trial is testingDocetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaWho this might be right forEsophagus Squamous Cell Carcinoma (SCC)Metastatic Cancer Sung Yong Oh 38
Not applicableLooking for participantsNCT07088354What this trial is testingDeep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant ImmunochemotherapyWho this might be right forEsophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more Tongji Hospital 300
Large-scale testing (Phase 3)Ended earlyNCT04689594What this trial is testingEvaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk GroupWho this might be right forSuperficial Esophageal Cancer CellSeed Inc. 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05659251What this trial is testingSerplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell CarcinomaNeoadjuvant Therapy Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Large-scale testing (Phase 3)Study completedNCT00002631What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the EsophagusWho this might be right forEsophageal Cancer Radiation Therapy Oncology Group 298
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Not applicableLooking for participantsNCT06792786What this trial is testingProspective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA MonitoringWho this might be right forEsophageal CancerctDNA The Central Hospital of Lishui City 30
Testing effectiveness (Phase 2)Study completedNCT00948961What this trial is testingCDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Who this might be right forAdvanced Malignancies Celldex Therapeutics 70
Not applicableLooking for participantsNCT06979869What this trial is testingInvestigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal CarcinomaWho this might be right forEsophageal Cancer Xijing Hospital 300
Testing effectiveness (Phase 2)Temporarily pausedNCT00048529What this trial is testingStudy of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusWho this might be right forGastric CancerEsophageal Neoplasms Tularik 70